Compugen Ltd.
NASDAQ Global MarketTotal Valuation
Compugen Ltd. carries a market capitalization of 244.89M, placing it among publicly traded companies globally. Its enterprise value stands at 80.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 244.89M |
| Enterprise Value | 80.07M |
Share Statistics
Compugen Ltd. currently has 94.55M shares outstanding.
| Shares Outstanding | 94.55M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Compugen Ltd. trades at a trailing price-to-earnings ratio of 5.73. The price-to-sales ratio is 2.73, and the price-to-book ratio stands at 2.28.
| PE Ratio | 5.73 |
| PS Ratio | 2.73 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 1.08 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 2.64 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.08 |
| EV / EBITDA | 2.64 |
| EV / EBIT | 2.64 |
| EV / FCF | N/A |
Financial Position
Compugen Ltd. maintains a current ratio of 5.72, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.72 |
| Quick Ratio | 5.72 |
| Debt / Equity | 3.41 |
| Debt / EBITDA | 0.10 |
| Interest Coverage | N/A |
Financial Efficiency
Compugen Ltd. posts a return on equity of 50.64 and a return on invested capital of 41.73.
| Return on Equity (ROE) | 50.64 |
| Return on Assets (ROA) | 28.74 |
| Return on Invested Capital (ROIC) | 41.73 |
| Return on Capital Employed (ROCE) | 48.55 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Compugen Ltd. has paid 52,000.00 in income taxes, reflecting an effective tax rate of 0.15.
| Income Tax | 52,000.00 |
| Effective Tax Rate | 0.15 |
Stock Price Statistics
Compugen Ltd.'s stock has gained approximately 83.68794% over the past 52 weeks. The 50-day moving average sits at 2.40, while the 200-day moving average is 2.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | 83.68794% |
| 50-Day Moving Average | 2.40 |
| 200-Day Moving Average | 2.17 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Compugen Ltd. generated 74.00M in revenue and converted that into 35.19M in net income, yielding earnings per share of 0.37. EBITDA reached 30.30M, while operating income came in at 30.30M.
| Revenue | 74.00M |
| Gross Profit | 64.30M |
| Operating Income | 30.30M |
| Pretax Income | 35.24M |
| Net Income | 35.19M |
| EBITDA | 30.30M |
| EBIT | 30.30M |
| Earnings Per Share (EPS) | 0.37 |
Balance Sheet
Compugen Ltd. holds 125.30M in cash and equivalents against 3.02M in total debt, resulting in a net debt position of -10.28M. Total book value stands at 88.73M, with working capital of 106.78M providing operational flexibility.
| Cash & Cash Equivalents | 125.30M |
| Total Debt | 3.02M |
| Net Debt | -10.28M |
| Equity (Book Value) | 88.73M |
| Book Value Per Share | 0.94 |
| Working Capital | 106.78M |
Margins
Compugen Ltd. operates with a gross margin of 86.89, reflecting its pricing power and cost economics. The operating margin of 40.94 and net profit margin of 47.55 provide insight into operational efficiency.
| Gross Margin | 86.89 |
| Operating Margin | 40.94 |
| Pretax Margin | 47.63 |
| Profit Margin | 47.55 |
| EBITDA Margin | 40.94 |
Scores
Compugen Ltd. posts an Altman Z-Score of -0.11, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.11 |